[en] The introduction in 1996 of the HAART raised hopes for the eradication of HIV-1. Unfortunately, the discovery of latent HIV-1 reservoirs in CD4+ T cells and in the monocyte-macrophage lineage proved the optimism to be premature. The long-lived HIV-1 reservoirs constitute a major obstacle to the eradication of HIV-1. In this review, we focus on the establishment and maintenance of HIV-1 latency in the two major targets for HIV-1: the CD4+ T cells and the monocyte-macrophage lineage. Understanding the cell-type molecular mechanisms of establishment, maintenance, and reactivation of HIV-1 latency in these reservoirs is crucial for efficient therapeutic intervention. A complete viral eradication, the holy graal for clinicians, might be achieved by strategic interventions targeting latently and productively infected cells. We suggest that new approaches, such as the combination of different kinds of proviral activators, may help to reduce dramatically the size of latent HIV-1 reservoirs in patients on HAART.
Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W., Montagnier, L. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871. (Pubitemid 13080157)
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., Mc- Mahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., Emini, E. A., Chodakewitz, J. A. (1997) Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337, 734-739. (Pubitemid 27417972)
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron Jr., J. J., Feinberg, J. E., Balfour Jr., H. H., Deyton, L. R., Chodakewitz, J. A., Fischl, M. A. (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med. 337, 725-733.
Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., Ho, D. D. (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-191. (Pubitemid 27209434)
Geeraert, L., Kraus, G., Pomerantz, R. J. (2008) Hide-and-seek: the challenge of viral persistence in HIV-1 infection. Annu. Rev. Med. 59, 487-501. (Pubitemid 351287951)
Harrigan, P. R., Whaley, M., Montaner, J. S. (1999) Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS 13, F59-F62. (Pubitemid 29240180)
Zhang, L., Chung, C., Hu, B. S., He, T., Guo, Y., Kim, A. J., Skulsky, E., Jin, X., Hurley, A., Ramratnam, B., Markowitz, M., Ho, D. D. (2000) Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J. Clin. Invest. 106, 839-845.
Chun, T. W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., Kuo, Y. H., Brookmeyer, R., Zeiger, M. A., Barditch-Crovo, P., Siliciano, R. F. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183-188. (Pubitemid 27209433)
Chun, T. W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., Siliciano, R. F. (1995) In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1, 1284-1290.
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., Gallant, J., Markowitz, M., Ho, D. D., Richman, D. D., Siliciano, R. F. (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295-1300. (Pubitemid 27495742)
Wong, J. K., Hezareh, M., Gunthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., Richman, D. D. (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291-1295. (Pubitemid 27495741)
Chun, T. W., Engel, D., Berrey, M. M., Shea, T., Corey, L., Fauci, A. S. (1998) Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 95, 8869-8873. (Pubitemid 28350581)
Strain, M. C., Gunthard, H. F., Havlir, D. V., Ignacio, C. C., Smith, D. M., Leigh-Brown, A. J., Macaranas, T. R., Lam, R. Y., Daly, O. A., Fischer, M., Opravil, M., Levine, H., Bacheler, L., Spina, C. A., Richman, D. D., Wong, J. K. (2003) Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc. Natl. Acad. Sci. USA 100, 4819-4824. (Pubitemid 36457812)
Pierson, T., Hoffman, T. L., Blankson, J., Finzi, D., Chadwick, K., Margolick, J. B., Buck, C., Siliciano, J. D., Doms, R. W., Siliciano, R. F. (2000) Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1. J. Virol. 74, 7824-7833. (Pubitemid 30641626)
Chanel, C., Staropoli, I., Baleux, F., Amara, A., Valenzuela-Fernandez, A., Virelizier, J. L., Arenzana-Seisdedos, F., Altmeyer, R. (2002) Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells. AIDS 16, 2337-2340. (Pubitemid 35449022)
Eckstein, D. A., Penn, M. L., Korin, Y. D., Scripture-Adams, D. D., Zack, J. A., Kreisberg, J. F., Roederer, M., Sherman, M. P., Chin, P. S., Goldsmith, M. A. (2001) HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity 15, 671-682. (Pubitemid 33016451)
Persaud, D., Zhou, Y., Siliciano, J. M., Siliciano, R. F. (2003) Latency in human immunodeficiency virus type 1 infection: no easy answers. J. Virol. 77, 1659-1665. (Pubitemid 36109978)
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M. R., Ghattas, G., Brenchley, J. M., Schacker, T. W., Hill, B. J., Douek, D. C., Routy, J. P., Haddad, E. K., Sékaly, R. P. (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15, 893-900.
Bailey, J. R., Sedaghat, A. R., Kieffer, T., Brennan, T., Lee, P. K., Wind-Rotolo, M., Haggerty, C. M., Kamireddi, A. R., Liu, Y., Lee, J., Persaud, D., Gallant, J. E., Cofrancesco Jr., J., Quinn, T. C., Wilke, C. O., Ray, S. C., Siliciano, J. D., Nettles, R. E., Siliciano, R. F. (2006) Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J. Virol. 80, 6441-6457. (Pubitemid 43927447)
Shen, L., Siliciano, R. F. (2008) Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J. Allergy Clin. Immunol. 122, 22-28. (Pubitemid 351899083)
Keele, B. F., Tazi, L., Gartner, S., Liu, Y., Burgon, T. B., Estes, J. D., Thacker, T. C., Crandall, K. A., McArthur, J. C., Burton, G. F. (2008) Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J. Virol. 82, 5548-5561. (Pubitemid 351705262)
Zhu, T., Muthui, D., Holte, S., Nickle, D., Feng, F., Brodie, S., Hwangbo, Y., Mullins, J. I., Corey, L. (2002) Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76, 707-716. (Pubitemid 34033369)
Alexaki, A., Liu, Y., Wigdahl, B. (2008) Cellular reservoirs of HIV-1 and their role in viral persistence. Curr. HIV Res. 6, 388-400.
Alexaki, A., Wigdahl, B. (2008) HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog. 4, e1000215.
Coleman, C. M., Wu, L. (2009) HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6, 51.
McElrath, M. J., Steinman, R. M., Cohn, Z. A. (1991) Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients. J. Clin. Invest. 87, 27-30.
Lambotte, O., Taoufik, Y., de Goer, M. G., Wallon, C., Goujard, C., Delfraissy, J. F. (2000) Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 23, 114-119. (Pubitemid 30316835)
Ellery, P. J., Tippett, E., Chiu, Y. L., Paukovics, G., Cameron, P. U., Solomon, A., Lewin, S. R., Gorry, P. R., Jaworowski, A., Greene, W. C., Sonza, S., Crowe, S. M. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178, 6581-6589. (Pubitemid 46717442)
Aquaro, S., Calio, R., Balzarini, J., Bellocchi, M. C., Garaci, E., Perno, C. F. (2002) Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antiviral Res. 55, 209-225. (Pubitemid 34718126)
Perno, C. F., Svicher, V., Ceccherini-Silberstein, F. (2006) Novel drug resistance mutations in HIV: recognition and clinical relevance. AIDS Rev. 8, 179-190. (Pubitemid 46138916)
Lore, K., Smed-Sorensen, A., Vasudevan, J., Mascola, J. R., Koup, R. A. (2005) Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. J. Exp. Med. 201, 2023-2033. (Pubitemid 41002937)
Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, R. A., Melroe, H., Cavert, W., Gebhard, K., Staskus, K., Zhang, Z. Q., Dailey, P. J., Balfour Jr., H. H., Erice, A., Perelson, A. S. (1996) Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274, 985-989. (Pubitemid 26398421)
Otero, M., Nunnari, G., Leto, D., Sullivan, J., Wang, F. X., Frank, I., Xu, Y., Patel, C., Dornadula, G., Kulkosky, J., Pomerantz, R. J. (2003) Peripheral blood dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART. AIDS Res. Hum. Retroviruses 19, 1097-1103. (Pubitemid 38037379)
Collman, R., Hassan, N. F., Walker, R., Godfrey, B., Cutilli, J., Hastings, J. C., Friedman, H., Douglas, S. D., Nathanson, N. (1989) Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J. Exp. Med. 170, 1149-1163. (Pubitemid 19250685)
Orenstein, J. M., Fox, C., Wahl, S. M. (1997) Macrophages as a source of HIV during opportunistic infections. Science 276, 1857-1861. (Pubitemid 27443662)
Caselli, E., Galvan, M., Cassai, E., Caruso, A., Sighinolfi, L., Di Luca, D. (2005) Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells. Blood 106, 2790-2797. (Pubitemid 41510755)
Kedzierska, K., Crowe, S. M. (2002) The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr. Med. Chem. 9, 1893-1903. (Pubitemid 35230257)
Swingler, S., Mann, A., Jacque, J., Brichacek, B., Sasseville, V. G., Williams, K., Lackner, A. A., Janoff, E. N., Wang, R., Fisher, D., Stevenson, M. (1999) HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5, 997-1103. (Pubitemid 29439569)
Verani, A., Gras, G., Pancino, G. (2005) Macrophages and HIV-1: dangerous liaisons. Mol. Immunol. 42, 195-212.
Slobod, K. S., Bennett, T. A., Freiden, P. J., Kechli, A. M., Howlett, N., Flynn, P. M., Head, D. R., Srivastava, D. K., Boyett, J. M., Brenner, M. K., Garcia, J. V. (1996) Mobilization of CD34+ progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults. Blood 88, 3329-3335. (Pubitemid 26365566)
Stanley, S. K., Kessler, S. W., Justement, J. S., Schnittman, S. M., Greenhouse, J. J., Brown, C. C., Musongela, L., Musey, K., Kapita, B., Fauci, A. S. (1992) CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J. Immunol. 149, 689-697.
Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Müssig, A., Allers, K., Schneider, T., Hofmann, J., Kücherer, C., Blau, O., Hofmann, W. K., Thiel, E. (2009) Long-term control of HIV by CCR5 Δ32/Δ32 stem-cell transplantation. N. Engl. J. Med. 360, 692-698.
Pelchen-Matthews, A., Kramer, B., Marsh, M. (2003) Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162, 443-455. (Pubitemid 36988553)
Raposo, G., Moore, M., Innes, D., Leijendekker, R., Leigh-Brown, A., Benaroch, P., Geuze, H. (2002) Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3, 718-729.
Ho, D. D., Rota, T. R., Hirsch, M. S. (1986) Infection of monocyte/macrophages by human T lymphotropic virus type III. J. Clin. Invest. 77, 1712-1715. (Pubitemid 16047120)
Nicholson, J. K., Cross, G. D., Callaway, C. S., McDougal, J. S. (1986) In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J. Immunol. 137, 323-329. (Pubitemid 16100307)
Antoni, B. A., Rabson, A. B., Kinter, A., Bodkin, M., Poli, G. (1994) NF-κ B-dependent and -independent pathways of HIV activation in a chronically infected T cell line. Virology 202, 684-694. (Pubitemid 2102829)
Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H., Fauci, A. S. (1989) Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86, 2365-2368. (Pubitemid 19102509)
Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A., Fauci, A. S. (1987) Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238, 800-802. (Pubitemid 18005239)
Han, Y., Wind-Rotolo, M., Yang, H. C., Siliciano, J. D., Siliciano, R. F. (2007) Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 5, 95-106. (Pubitemid 46151868)
Emiliani, S., Fischle, W., Ott, M., Van Lint, C., Amella, C. A., Verdin, E. (1998) Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J. Virol. 72, 1666-1670. (Pubitemid 28116960)
Emiliani, S., Van Lint, C., Fischle, W., Paras Jr., P., Ott, M., Brady, J., Verdin, E. (1996) A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc. Natl. Acad. Sci. USA 93, 6377-6381. (Pubitemid 26230313)
Marcello, A., Lusic, M., Pegoraro, G., Pellegrini, V., Beltram, F., Giacca, M. (2004) Nuclear organization and the control of HIV-1 transcription. Gene 326, 1-11. (Pubitemid 38068481)
Jordan, A., Bisgrove, D., Verdin, E. (2003) HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868-1877. (Pubitemid 36460143)
Kim, Y. K., Bourgeois, C. F., Pearson, R., Tyagi, M., West, M. J., Wong, J., Wu, S. Y., Chiang, C. M., Karn, J. (2006) Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency. EMBO J. 25, 3596-3604. (Pubitemid 44264870)
Cassol, E., Alfano, M., Biswas, P., Poli, G. (2006) Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J. Leukoc. Biol. 80, 1018-1030. (Pubitemid 44646308)
Bosque, A., Planelles, V. (2009) Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood 113, 58-65.
Brooks, D. G., Kitchen, S. G., Kitchen, C. M., Scripture-Adams, D. D., Zack, J. A. (2001) Generation of HIV latency during thymopoiesis. Nat. Med. 7, 459-464.
Sundell, I. B., Koka, P. S. (2006) Chimeric SCID-hu model as a human hematopoietic stem cell host that recapitulates the effects of HIV-1 on bone marrow progenitors in infected patients. J. Stem Cells 1, 283-300.
Barber, S. A., Gama, L., Dudaronek, J. M., Voelker, T., Tarwater, P. M., Clements, J. E. (2006) Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. J. Infect. Dis. 193, 963-970.
Hazuda, D. J., Young, S. D., Guare, J. P., Anthony, N. J., Gomez, R. P., Wai, J. S., Vacca, J. P., Handt, L., Motzel, S. L., Klein, H. J., Dornadula, G., Danovich, R. M., Witmer, M. V., Wilson, K. A., Tussey, L., Schleif, W. A., Gabryelski, L. S., Jin, L., Miller, M. D., Casimiro, D. R., Emini, E. A., Shiver, J. W. (2004) Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. Science 305, 528-532. (Pubitemid 38971345)
Hofman, M. J., Higgins, J., Matthews, T. B., Pedersen, N. C., Tan, C., Schinazi, R. F., North, T. W. (2004) Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 48, 3483-3490. (Pubitemid 39129349)
North, T. W., Van Rompay, K. K., Higgins, J., Matthews, T. B., Wadford, D. A., Pedersen, N. C., Schinazi, R. F. (2005) Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1. J. Virol. 79, 7349-7354. (Pubitemid 40756770)
Yamakami, K., Honda, M., Takei, M., Ami, Y., Kitamura, N., Nishinarita, S., Sawada, S., Horie, T. (2004) Early bone marrow hematopoietic defect in simian/human immunodeficiency virus C2/1-infected macaques and relevance to advance of disease. J. Virol. 78, 10906-10910. (Pubitemid 39299630)
Thiebot, H., Louache, F., Vaslin, B., de Revel, T., Neildez, O., Larghero, J., Vainchenker, W., Dormont, D., Le Grand, R. (2001) Early and persistent bone marrow hematopoiesis defect in simian/human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection. J. Virol. 75, 11594-11602. (Pubitemid 33063251)
Banda, N. K., Simon, G. R., Sipple, J. D., Terrell, K. L., Archer, P., Shpall, E. J., Akkina, R. K., Myers, A. M., Harrison, G. S. (1999) Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals. Biol. Blood Marrow Transplant. 5, 162-172.
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., Chen, I. S. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222. (Pubitemid 20149353)
Bukrinsky, M. I., Sharova, N., Dempsey, M. P., Stanwick, T. L., Bukrinskaya, A. G., Haggerty, S., Stevenson, M. (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89, 6580-6584.
Chiu, Y. L., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W., Greene, W. C. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435, 108-114. (Pubitemid 40655917)
Korin, Y. D., Zack, J. A. (1999) Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes. J. Virol. 73, 6526-6532. (Pubitemid 29327833)
Zack, J. A., Haislip, A. M., Krogstad, P., Chen, I. S. (1992) Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66, 1717-1725.
Cara, A., Klotman, M. E. (2006) Retroviral E-DNA: persistence and gene expression in nondividing immune cells. J. Leukoc. Biol. 80, 1013-1017. (Pubitemid 44646307)
Kelly, J., Beddall, M. H., Yu, D., Iyer, S. R., Marsh, J. W., Wu, Y. (2008) Human macrophages support persistent transcription from unintegrated HIV-1 DNA. Virology 372, 300-312.
Bukrinsky, M. I., Stanwick, T. L., Dempsey, M. P., Stevenson, M. (1991) Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427.
Stevenson, M., Stanwick, T. L., Dempsey, M. P., Lamonica, C. A. (1990) HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551-1560.
Marcello, A. (2006) Latency: the hidden HIV-1 challenge. Retrovirology 3, 7.
Jordan, A., Defechereux, P., Verdin, E. (2001) The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20, 1726-1738.
Schroder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R., Bushman, F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529.
Wu, X., Li, Y., Crise, B., Burgess, S. M. (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749-1751.
Han, Y., Lassen, K., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F., Siliciano, J. D. (2004) Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol. 78, 6122-6133.
Han, Y., Lin, Y. B., An, W., Xu, J., Yang, H. C., O'Connell, K., Dordai, D., Boeke, J. D., Siliciano, J. D., Siliciano, R. F. (2008) Orientation- dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 4, 134-146.
Eszterhas, S. K., Bouhassira, E. E., Martin, D. I., Fiering, S. (2002) Transcriptional interference by independently regulated genes occurs in any relative arrangement of the genes and is influenced by chromosomal integration position. Mol. Cell. Biol. 22, 469-479.
Lassen, K., Han, Y., Zhou, Y., Siliciano, J., Siliciano, R. F. (2004) The multifactorial nature of HIV-1 latency. Trends Mol. Med. 10, 525-531.
Lenasi, T., Contreras, X., Peterlin, B. M. (2008) Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell Host Microbe 4, 123-133.
Duverger, A., Jones, J., May, J., Bibollet-Ruche, F., Wagner, F.A., Cron, R.Q., Kutsch, O. (2009) Determinants of the establishment of human immunodeficiency virus type 1 latency. J. Virol. 83, 3078-3093.
Agosto, L. M., Yu, J. J., Dai, J., Kaletsky, R., Monie, D., O'Doherty, U. (2007) HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. Virology 368, 60-72.
Swiggard, W. J., Baytop, C., Yu, J. J., Dai, J., Li, C., Schretzenmair, R., Theodosopoulos, T., O'Doherty, U. (2005) Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J. Virol. 79, 14179-14188.
Nelson, D. E., Ihekwaba, A. E., Elliott, M., Johnson, J. R., Gibney, C. A., Foreman, B. E., Nelson, G., See, V., Horton, C. A., Spiller, D. G., Edwards, S. W., McDowell, H. P., Unitt, J. F., Sullivan, E., Grimley, R., Benson, N., Broomhead, D., Kell, D. B., White, M. R. (2004) Oscillations in NF-κB signaling control the dynamics of gene expression. Science 306, 704-708. (Pubitemid 39440922)
Weinberger, L. S., Burnett, J. C., Toettcher, J. E., Arkin, A. P., Schaffer, D. V. (2005) Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122, 169-182.
Weinberger, L. S., Dar, R. D., Simpson, M. L. (2008) Transient-mediated fate determination in a transcriptional circuit of HIV. Nat. Genet. 40, 466-470.
Weinberger, L. S., Schaffer, D. V., Arkin, A. P. (2003) Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection. J. Virol. 77, 10028-10036.
Weinberger, L. S., Shenk, T. (2007) An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer. PLoS Biol. 5, e9.
Pearson, R., Kim, Y. K., Hokello, J., Lassen, K., Friedman, J., Tyagi, M., Karn, J. (2008) Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J. Virol. 82, 12291-12303.
Mancebo, H. S., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D., Price, D., Flores, O. (1997) P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11, 2633-2644.
Wei, P., Garber, M. E., Fang, S. M., Fischer, W. H., Jones, K. A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92, 451-462.
Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M. B., Price, D. H. (1997) Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11, 2622-2632.
Liou, L. Y., Herrmann, C. H., Rice, A. P. (2004) HIV-1 infection and regulation of Tat function in macrophages. Int. J. Biochem. Cell Biol. 36, 1767-1775.
Dong, C., Kwas, C., Wu, L. (2009) Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J. Virol. 83, 3518-3527.
Correll, P. H., Morrison, A. C., Lutz, M. A. (2004) Receptor tyrosine kinases and the regulation of macrophage activation. J. Leukoc. Biol. 75, 731-737.
Klatt, A., Zhang, Z., Kalantari, P., Hankey, P. A., Gilmour, D. S., Henderson, A. J. (2008) The receptor tyrosine kinase RON represses HIV-1 transcription by targeting RNA polymerase II processivity. J. Immunol. 180, 1670-1677.
Lee, E. S., Kalantari, P., Tsutsui Section, S., Klatt, A., Holden, J., Correll, P. H., Power Section, C., Henderson, A. J. (2004) RON receptor tyrosine kinase, a negative regulator of inflammation, inhibits HIV-1 transcription in monocytes/macrophages and is decreased in brain tissue from patients with AIDS. J. Immunol. 173, 6864-6872.
Kieffer, T. L., Finucane, M. M., Nettles, R. E., Quinn, T. C., Broman, K. W., Ray, S. C., Persaud, D., Siliciano, R. F. (2004) Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. J. Infect. Dis. 189, 1452-1465.
Gekonge, B. N., Schiralli, G., Schlegel, R. A., Henderson, A. J. (2006) Signal transduction induced by apoptotic cells inhibits HIV transcription in monocytes/macrophages. J. Leukoc. Biol. 80, 953-960.
Hayden, M. S., Ghosh, S. (2004) Signaling to NF-κB. Genes Dev. 18, 2195-2224.
Schmid, R. M., Liptay, S., Betts, J. C., Nabel, G. J. (1994) Structural and functional analysis of NF-κ B. Determinants of DNA binding specificity and protein interaction. J. Biol. Chem. 269, 32162-32167.
Pinti, M., Biswas, P., Troiano, L., Nasi, M., Ferraresi, R., Mussini, C., Vecchiet, J., Esposito, R., Paganelli, R., Cossarizza, A. (2003) Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1. Exp. Biol. Med. (Maywood) 228, 1346-1354.
Herbein, G., Khan, K. A. (2008) Is HIV infection a TNF receptor signaling-driven disease? Trends Immunol. 29, 61-67.
Giri, M. S., Nebozyhn, M., Raymond, A., Gekonge, B., Hancock, A., Creer, S., Nicols, C., Yousef, M., Foulkes, A. S., Mounzer, K., Shull, J., Silvestri, G., Kostman, J., Collman, R. G., Showe, L., Montaner, L. J. (2009) Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance. J. Immunol. 182, 4459-4470.
Klase, Z., Winograd, R., Davis, J., Carpio, L., Hildreth, R., Heydarian, M., Fu, S., McCaffrey, T., Meiri, E., Ayash-Rashkovsky, M., Gilad, S., Bentwich, Z., Kashanchi, F. (2009) HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6, 18.
Fischle, W., Wang, Y., Allis, C. D. (2003) Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15, 172-183.
Van Lint, C. (2000) Role of chromatin in HIV-1 transcriptional regulation. Adv. Pharmacol. 48, 121-160.
Van Lint, C., Emiliani, S., Ott, M., Verdin, E. (1996) Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15, 1112-1120.
Verdin, E., Paras Jr., P., Van Lint, C. (1993) Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12, 3249-3259.
Coull, J. J., Romerio, F., Sun, J. M., Volker, J. L., Galvin, K. M., Davie, J. R., Shi, Y., Hansen, U., Margolis, D. M. (2000) The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J. Virol. 74, 6790-6799.
Hsia, S. C., Shi, Y. B. (2002) Chromatin disruption and histone acetylation in regulation of the human immunodeficiency virus type 1 long terminal repeat by thyroid hormone receptor. Mol. Cell. Biol. 22, 4043-4052.
Williams, S. A., Chen, L. F., Kwon, H., Ruiz-Jarabo, C. M., Verdin, E., Greene, W. C. (2006) NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25, 139-149.
Jiang, G., Espeseth, A., Hazuda, D. J., Margolis, D. M. (2007) c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J. Virol. 81, 10914-10923.
Du Chene, I., Basyuk, E., Lin, Y. L., Triboulet, R., Knezevich, A., Chable-Bessia, C., Mettling, C., Baillat, V., Reynes, J., Corbeau, P., Bertrand, E., Marcello, A., Emiliani, S., Kiernan, R., Benkirane, M. (2007) Suv39H1 and HP1γ are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J. 26, 424-435.
Avram, D., Fields, A., Pretty On Top, K., Nevrivy, D. J., Ishmael, J. E., Leid, M. (2000) Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J. Biol. Chem. 275, 10315-10322.
Marban, C., Redel, L., Suzanne, S., Van Lint, C., Lecestre, D., Chasserot-Golaz, S., Leid, M., Aunis, D., Schaeffer, E., Rohr, O. (2005) COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells. Nucleic Acids Res. 33, 2318-2331.
Rohr, O., Lecestre, D., Chasserot-Golaz, S., Marban, C., Avram, D., Aunis, D., Leid, M., Schaeffer, E. (2003) Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells. J. Virol. 77, 5415-5427.
Marban, C., Suzanne, S., Dequiedt, F., de Walque, S., Redel, L., Van Lint, C., Aunis, D., Rohr, O. (2007) Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J. 26, 412-423.
Vazquez, N., Greenwell-Wild, T., Marinos, N. J., Swaim, W. D., Nares, S., Ott, D. E., Schubert, U., Henklein, P., Orenstein, J. M., Sporn, M. B., Wahl, S. M. (2005) Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J. Virol. 79, 4479-4491.
Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G., Sawaya, B.E., Zeichner, S.L., Aunis, D., Van Lint, C., Rohr, O. (2009) p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene 28, 3380-3389.
Williams, S. A., Greene, W. C. (2007) Regulation of HIV-1 latency by T-cell activation. Cytokine 39, 63-74.
Lusic, M., Marcello, A., Cereseto, A., Giacca, M. (2003) Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J. 22, 6550-6561. (Pubitemid 38009602)
Rohr, O., Marban, C., Aunis, D., Schaeffer, E. (2003) Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. J. Leukoc. Biol. 74, 736-749. (Pubitemid 38040350)
Brady, J., Kashanchi, F. (2005) Tat gets the "green" light on transcription initiation. Retrovirology 2, 69.
Pereira, L. A., Bentley, K., Peeters, A., Churchill, M. J., Deacon, N. J. (2000) A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28, 663-668. (Pubitemid 30068248)
Garcia, J. A., Harrich, D., Soultanakis, E., Wu, F., Mitsuyasu, R., Gaynor, R. B. (1989) Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 8, 765-778. (Pubitemid 19273248)
Kingsman, S. M., Kingsman, A. J. (1996) The regulation of human immunodeficiency virus type-1 gene expression. Eur. J. Biochem. 240, 491-507. (Pubitemid 26321148)
Ganesh, L., Burstein, E., Guha-Niyogi, A., Louder, M. K., Mascola, J. R., Klomp, L. W., Wijmenga, C., Duckett, C. S., Nabel, G. J. (2003) The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature 426, 853-857. (Pubitemid 38056872)
Bird, A. P., Wolffe, A. P. (1999) Methylation-induced repression - belts, braces, and chromatin. Cell 99, 451-454.
Ishida, T., Hamano, A., Koiwa, T., Watanabe, T. (2006) 5′ Long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals. Retrovirology 3, 69. (Pubitemid 44642564)
O'Brien, M. C., Ueno, T., Jahan, N., Zajac-Kaye, M., Mitsuya, H. (1995)
Pion, M., Jordan, A., Biancotto, A., Dequiedt, F., Gondois-Rey, F., Rondeau, S., Vigne, R., Hejnar, J., Verdin, E., Hirsch, I. (2003) Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation. J. Virol. 77, 4025-4032. (Pubitemid 36350943)
Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V., Verdin, E. (2009) Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 5, e1000495.
Ambros, V., Chen, X. (2007) The regulation of genes and genomes by small RNAs. Development 134, 1635-1641. (Pubitemid 46796561)
Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
Yeung, M. L., Benkirane, M., Jeang, K. T. (2007) Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions? Retrovirology 4, 74.
Triboulet, R., Mari, B., Lin, Y. L., Chable-Bessia, C., Bennasser, Y., Lebrigand, K., Cardinaud, B., Maurin, T., Barbry, P., Baillat, V., Reynes, J., Corbeau, P., Jeang, K. T., Benkirane, M. (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315, 1579-1582. (Pubitemid 46449475)
Huang, J., Wang, F., Argyris, E., Chen, K., Liang, Z., Tian, H., Huang, W., Squires, K., Verlinghieri, G., Zhang, H. (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13, 1241-1247. (Pubitemid 47530631)
Chun, T. W., Justement, J. S., Lempicki, R. A., Yang, J., Dennis Jr., G., Hallahan, C. W., Sanford, C., Pandya, P., Liu, S., McLaughlin, M., Ehler, L. A., Moir, S., Fauci, A. S. (2003) Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proc. Natl. Acad. Sci. USA 100, 1908-1913. (Pubitemid 36254547)
Wang, X., Ye, L., Hou, W., Zhou, Y., Wang, Y. J., Metzger, D. S., Ho, W. Z. (2009) Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113, 671-674.
Lassen, K. G., Ramyar, K. X., Bailey, J. R., Zhou, Y., Siliciano, R. F. (2006) Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog. 2, e68.
Medzhitov, R., Littman, D. (2008) HIV immunology needs a new direction. Nature 455, 591.
Armitage, A. E., McMichael, A. J., Drakesmith, H. (2008) Reflecting on a quarter century of HIV research. Nat. Immunol. 9, 823-826.
Johnston, M. I., Fauci, A. S. (2007) An HIV vaccine - evolving concepts. N. Engl. J. Med. 356, 2073-2081.
Fauci, A. S., Johnston, M. I., Dieffenbach, C. W., Burton, D. R., Hammer, S. M., Hoxie, J. A., Martin, M., Overbaugh, J., Watkins, D. I., Mahmoud, A., Greene, W. C. (2008) HIV vaccine research: the way forward. Science 321, 530-532.
Chun, T. W., Davey Jr., R. T., Ostrowski, M., Shawn Justement, J., Engel, D., Mullins, J. I., Fauci, A. S. (2000) Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat. Med. 6, 757-761.
Nickle, D. C., Jensen, M. A., Shriner, D., Brodie, S. J., Frenkel, L. M., Mittler, J. E., Mullins, J. I. (2003) Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J. Virol. 77, 5540-5546. (Pubitemid 36460971)
McGee, B., Smith, N., Aweeka, F. (2006) HIV pharmacology: barriers to the eradication of HIV from the CNS. HIV Clin. Trials 7, 142-153. (Pubitemid 44309004)
Sawchuk, R. J., Yang, Z. (1999) Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system. Adv. Drug Deliv. Rev. 39, 5-31.
Solas, C., Lafeuillade, A., Halfon, P., Chadapaud, S., Hittinger, G., Lacarelle, B. (2003) Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 47, 238-243. (Pubitemid 36070370)
Perno, C. F., Newcomb, F. M., Davis, D. A., Aquaro, S., Humphrey, R. W., Calio, R., Yarchoan, R. (1998) Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. J. Infect. Dis. 178, 413-422. (Pubitemid 28347923)
Hermankova, M., Ray, S. C., Ruff, C., Powell-Davis, M., Ingersoll, R., D'Aquila, R. T., Quinn, T. C., Siliciano, J. D., Siliciano, R. F., Persaud, D. (2001) HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA 286, 196-207. (Pubitemid 32640851)
Nettles, R. E., Kieffer, T. L., Kwon, P., Monie, D., Han, Y., Parsons, T., Cofrancesco Jr., J., Gallant, J. E., Quinn, T. C., Jackson, B., Flexner, C., Carson, K., Ray, S., Persaud, D., Siliciano, R. F. (2005) Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. JAMA 293, 817-829. (Pubitemid 40250365)
Baba, M. (2006) Recent status of HIV-1 gene expression inhibitors. Antiviral Res. 71, 301-306. (Pubitemid 44223751)
Gatignol, A., Jeang, K. T. (2000) Tat as a transcriptional activator and a potential therapeutic target for HIV-1. Adv. Pharmacol. 48, 209-227.
Stevens, M., De Clercq, E., Balzarini, J. (2006) The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention. Med. Res. Rev. 26, 595-625. (Pubitemid 44230414)
Baba, M. (1997) Cellular factors as alternative targets for inhibition of HIV-1. Antiviral Res. 33, 141-152.
De Clercq, E. (2002) New anti-HIV agents and targets. Med. Res. Rev. 22, 531-565.
Daelemans, D., Vandamme, A. M., De Clercq, E. (1999) Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy. Antivir. Chem. Chemother. 10, 1-14. (Pubitemid 29110119)
Berna, A., Bernier, F., Chabriere, E., Perera, T., Scott, K. (2008) DING proteins; novel members of a prokaryotic phosphate-binding protein superfamily which extends into the eukaryotic kingdom. Int. J. Biochem. Cell Biol. 40, 170-175. (Pubitemid 350137871)
Darbinian-Sarkissian, N., Darbinyan, A., Otte, J., Radhakrishnan, S., Sawaya, B. E., Arzumanyan, A., Chipitsyna, G., Popov, Y., Rappaport, J., Amini, S., Khalili, K. (2006) p27(SJ), a novel protein in St. John's Wort, that suppresses expression of HIV-1 genome. Gene Ther. 13, 288-295. (Pubitemid 43223097)
Mukerjee, R., Deshmane, S. L., Darbinian, N., Czernik, M., Khalili, K., Amini, S., Sawaya, B. E. (2008) St. John's Wort protein, p27SJ, regulates the MCP-1 promoter. Mol. Immunol. 45, 4028-4035.
Biswas, P., Poli, G., Kinter, A. L., Justement, J. S., Stanley, S. K., Maury, W. J., Bressler, P., Orenstein, J. M., Fauci, A. S. (1992) Interferon γ induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J. Exp. Med. 176, 739-750.
Butera, S. T., Perez, V. L., Wu, B. Y., Nabel, G. J., Folks, T. M. (1991) Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection. J. Virol. 65, 4645-4653.
Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S., Rabson, A. B. (1989) Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κ B sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86, 5974-5978. (Pubitemid 19217570)
Kutsch, O., Levy, D. N., Kosloff, B. R., Shaw, G. M., Benveniste, E. N. (2003) CD154-CD40-induced reactivation of latent HIV-1 infection. Virology 314, 261-270. (Pubitemid 37153315)
Poli, G., Kinter, A. L., Fauci, A. S. (1994) Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 91, 108-112. (Pubitemid 24018652)
Folks, T. M., Justement, J., Kinter, A., Schnittman, S., Orenstein, J., Poli, G., Fauci, A. S. (1988) Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140, 1117-1122. (Pubitemid 18088576)
Korin, Y. D., Brooks, D. G., Brown, S., Korotzer, A., Zack, J. A. (2002) Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J. Virol. 76, 8118-8123. (Pubitemid 34809066)
Kulkosky, J., Culnan, D. M., Roman, J., Dornadula, G., Schnell, M., Boyd, M. R., Pomerantz, R. J. (2001) Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood 98, 3006-3015.
Laughlin, M. A., Chang, G. Y., Oakes, J. W., Gonzalez-Scarano, F., Pomerantz, R. J. (1995) Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-κ B. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9, 332-339.
Laughlin, M. A., Zeichner, S., Kolson, D., Alwine, J. C., Seshamma, T., Pomerantz, R. J., Gonzalez-Scarano, F. (1993) Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA. Virology 196, 496-505. (Pubitemid 23283446)
Quivy, V., Van Lint, C. (2002) Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system. Biochem. Pharmacol. 64, 925-934. (Pubitemid 35232266)
Sheridan, P. L., Mayall, T. P., Verdin, E., Jones, K. A. (1997) Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev. 11, 3327-3340. (Pubitemid 28023957)
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., Coffin, J. M., Bosch, R. J., Margolis, D. M. (2005) Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366, 549-555. (Pubitemid 41140329)
Archin, N. M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D., Margolis, D. M. (2009) Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res. Hum. Retroviruses 25, 207-212.
Scheller, C., Sopper, S., Koutsilieri, E., Ludwig, S., Ter Meulen, V., Jassoy, C. (2003) Caspase inhibitors as a supplement in immune activation therapies to achieve eradication of HIV in its latent reservoirs. Ann. N. Y. Acad. Sci. 1010, 209-212. (Pubitemid 38264977)
Contreras, X., Barboric, M., Lenasi, T., Peterlin, B. M. (2007) HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription. PLoS Pathog. 3, 1459-1469. (Pubitemid 350085610)
Oguariri, R. M., Brann, T. W., Imamichi, T. (2007) Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors. J. Biol. Chem. 282, 3594-3604.
Tong-Starkesen, S. E., Luciw, P. A., Peterlin, B. M. (1989) Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J. Immunol. 142, 702-707.
Kutsch, O., Benveniste, E. N., Shaw, G. M., Levy, D. N. (2002) Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 76, 8776-8786. (Pubitemid 34864073)
Jones, J., Kosloff, B. R., Benveniste, E. N., Shaw, G. M., Kutsch, O. (2005) Amphotericin-B-mediated reactivation of latent HIV-1 infection. Virology 331, 106-116. (Pubitemid 39610458)
Mai, A. (2007) The therapeutic uses of chromatin-modifying agents. Expert Opin. Ther. Targets 11, 835-851.
Sagot-Lerolle, N., Lamine, A., Chaix, M. L., Boufassa, F., Aboulker, J. P., Costagliola, D., Goujard, C., Pallier, C., Delfraissy, J. F., Lambotte, O. (2008) Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir. AIDS 22, 1125-1129.
Siliciano, J. D., Lai, J., Callender, M., Pitt, E., Zhang, H., Margolick, J. B., Gallant, J. E., Cofrancesco Jr., J., Moore, R. D., Gange, S. J., Siliciano, R. F. (2007) Stability of the latent reservoir for HIV-1 in patients receiving valproic acid. J. Infect. Dis. 195, 833-836. (Pubitemid 46363928)
Yang, H. C., Shen, L., Siliciano, R. F., Pomerantz, J. L. (2009) Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proc. Natl. Acad. Sci. USA 106, 6321-6326.
Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J. S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., Martinelli, V., Veithen, E., Cherrier, T., Avettand, V., Poutrel, S., Piette, J., de Launoit, Y., Moutschen, M., Burny, A., Rouzioux, C., De Wit, S., Herbein, G., Rohr, O., Collette, Y., Lambotte, O., Clumeck, N., Van Lint, C. (2009) Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS One 4, e6093.
